Member Info for B2HS2L

Companies House Unaudited Financial Statement for year ended 30 April 2021.
Record for Celixir Innovations Ltd.

https://s3.eu-west-2.amazonaws.com/document-api-images-live.ch.gov.uk/docs/kAuZMT2iBtw7bhvioClbEGiBebi1GJtfZYv_3YuGEHE/application-pdf?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAWRGBDBV3PL4SSQWZ%2F20210628%2Feu-west-2%2Fs3%2Faws4_request&X-Amz-Date=20210628T061117Z&X-Amz-Expires=60&X-Amz-Security-Token=IQoJb3JpZ2luX2VjEJL%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCWV1LXdlc3QtMiJHMEUCIQCRkD%2FtGU9%2BDIdr5AHzLjDyFhuQGbiOB4yNwmmBgbdSqgIgPLRjJHEyi%2BpWZqA9aKTslYgYs3SjlZ6pfapaoDrX2zwq%2BgMIaxADGgw0NDkyMjkwMzI4MjIiDMF2dpFA5WwAXoGFzSrXA0JNK020jRulOqMKEK4KjtFnrpCcP24A7%2BPefvfdW6SNapw%2F6Kd85V4iu1eGtupyisGPS8cddGyVvUS5mLEu6J5l41do8tvDKL17%2FQUm4Dc0rYXNscQpb4YS2Kj0kWnK9hkO8iR0I30Ge0OHP3VUyPV1sR5lffZS2NGBpGHDArAkAgCragUwAQ3rnAloPF0ab%2B3atDMFz7a8FxLAHbx1nnwQ38staMTNIiHWk8feQUGjaTQxKS9GtZ9zqPozZmqERbDajqk2bay9O3nWLOfiMPYoRxnMB4DDZTQ%2FAn0jdCYfweIowESn4NdSU7M4vGZq9ouPvm0NeiMc%2F23FfjrOZCWUi%2F0f%2FywivRc5ZaZjYrT2YRsrHAitfx4wAIkVpbApG%2FcDP1X4z0tKGT5s8HcFBhtQRo2h4mngqfblJx0BcjLX3nWW4IrJRPDa1K0OEMYnH6MAhCtFNpPgod%2FqZ%2BV91MrQ8Mu5f0N77idGZEoQtevwxQj23tRMxbOn0BHPtBrTX%2BahSiZOOVROiiZgeWXR17VmY2iBW6%2FDO04hWzfAe7cLmlg%2B76GSFVAkPtSkal%2F8BmF2TpPocf5Sy3pQG0uqmeRAnPAVV1qEdJ0o0T3S%2BTyy1cHrjd6RbDDrzeSGBjqlAYZye12LhV%2BwJXKIHp42NUV3Qxv3Vin7oENVptaid45MPnjbcpP1EZYPfEZMaG513dE8JcBL6WjMmKUE6jeGgJi1zioPjclx9vX5L8jZ5qKFhpSU5Mx0W6JVjiJutGYK3va5r8okWy9NvFqTGehr4LWwVHFQNWN7zXUyHkxY9R%2FtvG%2BG8i2upG0SQyuz9hutxnXxh1vywBwBw***2aKTOXPtvq1L9w%3D%3D&X-Amz-SignedHeaders=host&response-content-disposition=inline%3Bfilename%3D%2210141208_aa_2021-06-14.pdf%22&X-Amz-Signature=f2a133f2ea5d049f957056d5a1279b6fe1d21d47a6f70da1606fa1cf844641ac

Roderic Fuerst - ex CEO of IT-IS International was also a Roche employee 2002-2010.
https://www.linkedin.com/in/rodericfuerst/?originalSubdomain=uk

Probably just coincidence, - no other recent hires are from Roche.

https://www.standard.co.uk/news/uk/uk-covid-latest-updates-matt-han****-sajid-javid-health-secretary-vaccines-under-30s-news-b942844.html

Incoming Health Secretary Sajid Javid has said his "most immediate priority" will be ending the Covid pandemic as soon as possible.

Speaking to the media for the first time since becoming Health Secretary on Saturday, Mr Javid said: "I was honoured to take up this position. I also know that it comes with a huge responsibility and I will do everything I can to make sure that I deliver for this great country.

"We are still in a pandemic and I want to see that come to an end as soon as possible and that will be my most immediate priority, to see that we can return to normal as soon and as quickly as possible."

It comes as half of all adults aged under 30 in England have received a first dose of a Covid vaccine by Sunday, the NHS has said.

More than 4.2 million people aged between 18 and 29 have received a jab in the three weeks after the coronavirus vaccination programme was opened up to those in their 20s.

++++

This is a remarkably naïve statement from Sajid, who seems to see himself succeeding without working with other world leaders.

I don't think he'll be hitting the ground running, without a much better briefing than he's had so far.

"Javid says his immediate priority is to end the Covid pandemic ASAP."

I take that to mean he see's himself doing the job past the next election.

Yes trouble.
We can help ourselves by only discussing information concerning the dispute that is in the public domain.

troublesome -
IF GM 'gives' DHSC too much in a dispute settlement, - it will give credence to the supposition that
NCYT provided DHSC with faulty goods.

IMO ShaunP felt there was more than a chance this had happened, but I totally disagree.

If faulty assays were provided, (after rigorous QA to retain and uphold ISO standards, that as far as we know nobody else has had reason to complain of), then the 09.04.2021 RNS's would not contain "the Company has taken legal advice and believes it has strong grounds to assert its contractual rights".
GM would have settled the dispute by using the arbitration measures before now without going to court.

So if DHSC HAVE called into question the quality of the assay delivered, (and they did accept quite a lot of PROmate, - hence the ",Company believes that Q1 PROmate™ sales may be sufficient to support the NHS current roll out plans for the remainder of 2021" statement, - why accept so much.

https://bourse.challenges.fr/actu/ALNOV/FR/81211/novacyt-chute-de-12-apres-son-point-sur-le-conflit-dhsc.html

21/05/21
Novacyt: 12% drop after its point on the DHSC conflict (CercleFinance.com) -

The stock fell nearly -12% after its update on its dispute with the UK Department of Health and Social Affairs (DHSC).

Novacyt warns that this conflict 'could now have a significant impact on the first quarter of 2021 revenue achieved with the DHSC'.

"Novacyt has sought legal advice regarding this dispute and believes it has a strong case to assert its contractual rights," oddo said.

The analyst points out that the NHS seems to be contesting the billing arrangements, giving up a risk of recognition of income.
'As a reminder, about 50% of Q1 2021 revenue came from sales at DHSC'.

'The uncertainties surrounding this dispute militate in favour of a certain degree of caution.
This legal knot risks continuing to maintain doubt and weigh on the stock," adds Oddo,
who remains underperforming on the stock with a target of 4.10 Euro.

Copyright (c) 2021 CercleFinance.com. All rights reserved.

French boursorama bb users have vouched for validity of Cercle Finance as a source, but unfortunately I don't think the translation is good, as the meaning is not crystal clear.

Any French speakers can do a better job please?

EXMEX, -
This job spec, - indeed the vacancy - contains nothing they did not need before.

"The role will manage documents (electronic and paper) within Quality Assurance and Regulatory Affairs to ensure that all GMP regulated documents are filed systematically and are easily retrievable. Duties will include managing intake, handling, and storage of quality documentation."

I feel this vacancy may have come about by retirement or a QA specialist leaving the company, so not necessarily indicative of an additional position.

Having said that, there may be new product(s) on the way, - but they aren't visible from publication of this vacancy.
If further (different) vacancies occur, they might be indicative of another production line.

Sajid Javid to replace Hankock

Orangutan -

Dr John Campbell video on "Ivermectin prophylactic study from India"

https://www.youtube.com/watch?v=XYv30g7TKVM

Well worth a visit.

I'm using the AVAST browser.
I'm not seeing any ads.

Bluelight, -
It will be a long time before airlines 'make a few quid' (I know what you meant).
They're all too busy stemming a tsunami of losses.

I think it's significant no directors have sold any shares (to my knowledge).

Oriens, -
The other option is that this amount of Federal money being made available for testing will trigger a US pharma to consider buying NCYT.
Novacyt's SNPsig system for Genomic sequencing is a candidate for the best (and fastest) technology for Global Surveillance. - Haven't seen a (USA) competitors announce a new system that competes on time to complete tests, and we have the Bioinformatics Surveillance Report showing very high levels of detection of VoC's etc:
https://twitter.com/NovacytGroup/status/1407380082990239755/photo/1
Even less reason to be out of this, if the above causes an offer to be made.

British and French govnt policy might interfere with a takeover of such a company as Novacyt.

Oriens, - I know where your coming from, but for me NCYT have to find a US partner / acquisition to gain access to a small part of these funds.

Oriens1
https://www.congress.gov/bill/117th-congress/house-bill/1319/text
Subtitle E—Testing
2401/2/3/4

Over $50 Bil in testing set to be appropriated in early Nov 2021.
Yes we did hear a US update due but did not appear.
The above amount to be signed off by Biden currently scheduled for Nov this year.
Best the sales teams are ready before then!

neil, - IF these people are not busy for part of the day as business is 'slack' presently, I'd certainly want them to contribute some time each day IF there skills are useful in export markets.

Oriens1
There are certain news items that crop up unannounced from NCYT occasionally, - not many but some.
Presently we await
1 DHSC dispute settlement (not wise to assume this is medium / long term problem)
2 Merger / Acquisition
3 FDA approvals, - "Expansion underway in US market, with establishment of Novacyt US Inc and appointment of a US General Manager, with up to 10 additional hires expected in H2 2021"

But NOT
New products released to market

WWTBOOTWTH...(When These Happen), - then we'll know who chose most wisely.

Might we have the team of 50 assisting with selling into USA / Germany for the present, if NHS / PHE business slow?

pmjh_temp -
Are you a new investor here, or just passing through?
Liking your contribution to SNG board, and hope you intend to stick around.

Dartron -
Kat Hassard on twitter has supplied in the past.